Gyre Therapeutics (GYRE) Reports In-Line Q4 EPS

March 17, 2025 5:26 PM EDT

Gyre Therapeutics (NASDAQ: GYRE) reported Q4 EPS of $0.00. Revenue for the quarter came in at $27.87 million.

For earnings history and earnings-related data on Gyre Therapeutics (GYRE) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK